Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes

Author(s): Al-Jarrah M, Matalka I, Aseri HA, Mohtaseb A, Smirnova IV, et al.

Abstract

Background: Endometrial cancer is one of the most common types of gynecologic cancers. The ability of exercise to reduce the risk of endometrial cancer in women with type 2 diabetes has been established, but no studies have examined this link in type 1 diabetes.A randomized, controlled animal study was designed using a standard rat model of type 1 diabetes. The goal of this study was to investigate the ability of exercise to prevent increased levels of endometrial cancer biomarkers, estrogen receptor (ERα) and p16, and endometrial hyperplasia associated with diabetes.

Methods: FORTY FEMALE RATS WERE RANDOMIZED INTO FOUR GROUPS: sedentary control, exercise control, sedentary or exercised diabetic. Diabetes was induced by alloxan injection. A 4-week treadmill training program was initiated with the development of diabetes. Endometrial tissues were evaluated for hyperplasia and ERα and p16 levels and subcellular localization using microscopy.

Results: Severe diabetes lead to hyperplasia in the endometrial tissue in 70% of sedentary diabetic rats. Exercise-trained diabetic rats and the non-diabetic rats displayed no hyperplasia. The expression of ERα increased significantly (p < 0.02) while the expression level of p16 decreased significantly (p < 0.04) in the diabetic sedentary group compared to the non-diabetic groups. Exercise training led to a reversal in the percentage of p16 and ERα positive cells in diabetic rats.

Conclusions: Severe diabetes leads to hyperplasia of the endometrial tissue and increased ERα levels and decreased p16 levels in rats, which can be prevented with aerobic exercise.

Keywords: Diabetes; Estrogen receptor alpha; P16; Endometrial hyperplasia; Endometrial cancer; Exercise.

Similar Articles

Incidence of endometrial hyperplasia

Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.

Seromucinous Tumors of the Ovary

Author(s): Kurman RJ, Shih IeM

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.

Modifiable risk factors for cancer

Author(s): Stein CJ, Colditz GA

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.

Risk factors for endometrial hyperplasia: results from a case-control study

Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.

High rate of endometrial hyperplasia in renal transplanted women

Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.

Clinical parameters linked with malignancy in endometrial polyps

Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.

Measuring inconsistency in meta-analyses

Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG

Quantifying heterogeneity in a meta-analysis

Author(s): Higgins JP, Thompson SG

Bias in meta-analysis detected by a simple, graphical test

Author(s): Egger M, Davey Smith G, Schneider M, Minder C

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women

Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.

Risk factors for adenomatous endometrial hyperplasia: a case-control study

Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.

Characteristics of women with a family history of ovarian cancer

Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.

Cigarette smoking, relative weight, and menopause

Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.

Tobacco smoking and cancer: a meta-analysis

Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.

Smoking and colorectal cancer: a meta-analysis

Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.

IUD use and the risk of endometrial cancer

Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N

Risk factors among young women with endometrial cancer: a Danish case-control study

Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.

A case-control study of cancer of the endometrium

Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.

Epidemiology of endometrial cancer

Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD

Family history and the risk of endometrial cancer

Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E